Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11753463 Therapeutic targeting of non-cellular structures

Patent 11753463 was granted and assigned to Orionis Biosciences on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Orionis Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Nikolai Kley

Leander Huyghe

Anje Cauwels

Jan Tavernier

Date of Patent

September 12, 2023

Patent Application Number

16301299

Date Filed

May 12, 2017

Patent Citations

US Patent 9534056 Engineered TAA antibody-TNFSF member ligand fusion molecules

US Patent 9732135 Targeting of human interferon antagonists

US Patent 9878014 Targeted human-interferon fusion proteins

US Patent 9914759 Targeted modified TNF family members

US Patent 10035835 Targeted modified TNF family members

US Patent 10072059 Targeting of human interferon antagonists

US Patent 10407480 Targeted modified TNF family members

US Patent 10787493 Targeted modified TNF family members

...

Patent Primary Examiner

Ilia I Ouspenski

The present invention relates, in part, to chimeric proteins that bind a non-cellular structure and their use as therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the chimeric proteins and their use in the treatment of various diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11753463 Therapeutic targeting of non-cellular structures

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool